Abstract
Germany Wound Care Management Investment Opportunities, Analysis and Forecasts
to 2012
Summary
This report is an essential source for in-depth information and data relating
to Germany wound care management market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the wound care management in
Germany
Scope
・ The report provides wound care management information broken down into
detailed categories and segments in Germany.
・ Total revenues, products
sold, end users, and average pricing.
・ Market shares of all the key
competitors.
・ Key pipeline products that are set to shape the market,
broken down by sector.
・ Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
・ Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the wound care management market in
Germany.
・ Evaluate and compare the attractiveness of the market in the
country.
・ Identify growth segments and opportunities in each industry
sector within the country.
・ Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
・ Analyze the competitiveness of the
market in the country and identify hotspots.
・ Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 15
2.1 What Is This Report About? 15
2.2 Definitions
15
2.2.1 Wound Care Management 15
3 Healthcare Sector Review 17
3.1 Healthcare Sector 17
3.2 Healthcare Expenditure 17
3.3 Healthcare
Infrastructure 21
3.3.1 Healthcare Personnel Data 21
3.3.2 Healthcare
Facilities Data 23
3.4 Healthcare Policy 28
4 Wound Care Management in
Germany 29
4.1 Wound Care Management Overall Revenues (2000-2012) 29
4.2 Wound Care Management Overall Volume (2000-2012) 35
4.3 Wound Care
Management Overall Company Shares (2005-2006) 38
5 Wound Closure Devices
in Germany 39
5.1 Wound Closure Devices Overall Revenues (2000-2012)
39
5.1.1 Skin Closure Devices Overall Revenues (2000-2012) 43
5.1.2
Hemostats Overall Revenues (2000-2012) 45
5.1.3 Tissue Sealants Overall
Revenues (2000-2012) 47
5.2 Wound Closure Devices Overall Volume
(2000-2012) 49
5.2.1 Skin Closure Devices Overall Volume (2000-2012)
51
5.2.2 Tissue Sealants Overall Volume (2000-2012) 53
5.2.3 Hemostats
Overall Volume (2000-2012) 55
5.3 Wound Closure Devices Average Price
(2000-2012) 57
5.3.1 Hemostats Average Price (2000-2012) 57
5.4 Wound
Closure Devices Distribution Share (2005-2006) 63
5.5 Wound Closure
Devices Company Share (2005-2006) 64
6 Ostomy in Germany 65
6.1 Ostomy
Overall Revenue (2000-2012) 65
6.2 Ostomy Overall Volume (2000-2012)
67
6.3 Ostomy Average Price (2000-2012) 69
6.4 Ostomy Distribution
Share (2005-2006) 71
6.5 Ostomy Company Share (2005-2006) 72
7 Advance
Wound Management in Germany 73
7.1 Advanced Wound Management Overall
Revenue (2000-2012) 73
7.2 Advanced Wound Management Overall Volume
(2000-2012) 75
7.3 Advanced Wound Management Average Price (2000-2012)
77
7.4 Advanced Wound Management Distribution Share (2005-2006) 79
7.5
Advanced Wound Management Company Share (2005-2006) 80
8 Traditional Wound
Management in Germany 81
8.1 Traditional Wound Management Overall Revenue
(2000-2012) 81
8.2 Traditional Wound Management Overall Volume (2000-2012)
83
8.3 Traditional Wound Management Average Price (2000-2012) 85
8.4
Traditional Wound Management Distribution Share (2005-2006) 87
8.5
Traditional Wound Management Company Share (2005-2006) 88
9 Compression
Therapy in Germany 89
9.1 Compression Therapy Overall Revenue (2000-2012)
89
9.2 Compression Therapy Overall Volume (2000-2012) 91
9.3
Compression Therapy Average Price (2000-2012) 93
9.4 Compression Therapy
Distribution Share (2005-2006) 95
9.5 Compression Therapy Company Share
(2005-2006) 96
10 The HARTMANN GROUP Company Profile 97
10.1 Company
Overview 97
10.2 Business Overview 97
10.2.1 Incontinence Management
97
10.2.2 Operating Theater Management 97
10.2.3 Other GROUP
Activities 98
10.2.4 Wound Management 98
10.2.5 Products 98
10.2.6
History 99
10.3 Value Chain Analysis 101
10.3.1 Manufacturing 101
10.3.2 Product Development 102
10.3.3 Sales and Marketing 102
10.4
SWOT Analysis 102
10.4.1 HARTMANN GROUP Strengths 102
10.4.2 HARTMANN
GROUP Weaknesses 103
10.4.3 HARTMANN GROUP Opportunities 104
10.4.4
HARTMANN GROUP Threats 104
10.5 Financial and Operational Review 106
10.6 Locations And Subsidiaries 108
11 Ethicon, Inc. Company Profile
110
11.1 Company Overview 110
11.2 Business Overview 110
11.2.1
Products 111
11.3 Locations And Subsidiaries 112
12 Coloplast A/S
Company Profile 114
12.1 Company Overview 114
12.2 Business Overview
114
12.2.1 Medical Care 114
12.2.2 Overview 114
12.2.3 Major
Products and Services 115
12.2.4 History 115
12.3 Value Chain Analysis
117
12.3.1 Manufacturing 117
12.3.2 Product Development 118
12.3.3
Sales and Marketing 119
12.4 SWOT Analysis 119
12.4.1 Coloplast A/S
Strengths 119
12.4.2 Coloplast A/S Weaknesses 120
12.4.3 Coloplast A/S
Opportunities 121
12.4.4 Coloplast A/S Threats 121
12.5 Financial and
Operational Review 122
12.5.1 Financial Statements 122
12.6 Financial
Ratios 123
12.7 Share Holding Structure 124
12.8 Locations And
Subsidiaries 124
13 Smith & Nephew Plc Company Profile 127
13.1
Company Overview 127
13.2 Business Overview 127
13.2.1 Advanced Wound
Management 127
13.2.2 Endoscopy 128
13.2.3 Reconstruction 128
13.2.4 Trauma and Clinical Therapies 129
13.2.5 Products 129
13.2.6
History 130
13.3 Value Chain Analysis 134
13.3.1 Manufacturing 134
13.3.2 Product Development 135
13.3.3 Sales and Marketing 136
13.4
SWOT Analysis 136
13.4.1 Smith & Nephew Plc Strengths 137
13.4.2 Smith
& Nephew Plc Weaknesses 137
13.4.3 Smith & Nephew Plc Opportunities
138
13.4.4 Smith & Nephew Plc Threats 138
13.5 Financial and
Operational Review 139
13.6 Locations And Subsidiaries 140
13.7 Smith
& Nephew Plc Pipeline Products 142
13.7.1 R3 Modular resurfacing
Acetabular system 142
13.7.2 R3 Ceramic-on-ceramic Acetabular System
142
14 Covidien Ltd./Tyco Healthcare Company Profile 143
14.1 Company
Overview 143
14.2 Business Overview 143
14.2.1 Imaging Solutions
143
14.2.2 Medical Devices 144
14.2.3 Medical Supplies 144
14.2.4
Pharmaceutical Products 145
14.2.5 Retail Products 145
14.2.6 Products
146
14.2.7 History 147
14.3 Value Chain Analysis 148
14.3.1
Manufacturing 148
14.3.2 Product Development 149
14.3.3 Sales and
Marketing 150
14.4 SWOT Analysis 150
14.4.1 Covidien Ltd./Tyco
Healthcare Strengths 151
14.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
151
14.4.3 Covidien Ltd./Tyco Healthcare Opportunities 152
14.4.4
Covidien Ltd./Tyco Healthcare Threats 153
14.5 Financial and Operational
Review 154
14.5.1 Financial Statements 154
14.5.2 Financial Ratios
155
14.6 Locations And Subsidiaries 156
14.7 Covidien Ltd./Tyco
Healthcare Pipeline Products 158
14.7.1 PleuraSeal Lung Sealant System
158
14.7.2 Sandman Intro CPAP Device 159
15 Regulation System 161
15.1 Medical Equipment Approval Process 161
15.1.1 Classification of
Medical Devices 161
15.2 Conformity Assessment Process 170
15.2.1
Class I devices 170
15.2.2 Class IIa devices 171
15.2.3 Class IIb
devices 172
15.2.4 Class III devices 173
15.3 Post Market Surveillance
173
16 Pricing and Reimbursement 174
16.1 SHI 174
16.1.1 Private
Health Insurance 174
16.1.2 Diagnosis Related Groups (DRG) 174
17
Distribution Structure 175
18 Financial Deals Landscape 176
18.1
Acquisition 176
18.1.1 Montagu Private Equity To Sell BSN Medical 176
19 Appendix 178
19.1 Global Markets Direct Research Methodology 178
19.2 Coverage 179
19.3 Secondary Research 179
19.4 Primary Research
180
19.5 Models 180
19.6 Forecasts 181
19.7 Expert Panels 181
19.8 Currency Conversion 182
19.9 Contact Us 183
19.10 Disclaimer
183
1.1 List of Tables
Table 1: Healthcare Personnel by Region in
Germany, 2004 21
Table 2: Doctors by Specialty in Germany, 2000-2004
22
Table 3: Hospitals by Region in Germany, 2004 23
Table 4: Hospital
Beds by Region in Germany, 2004 24
Table 5: Rehabilitation Centers by
Region in Germany, 2004 25
Table 6: Rehabilitation Center Beds by Region
in Germany, 2004 26
Table 7: Discharges by Diagnosis in Germany, 2004
27
Table 8: Wound Care Management, Germany, Overall Revenues ($ mn),
2000-2012 29
Table 9: Wound Care Management, Germany, Overall Revenues ($
mn), Historic, 2000-2007 30
Table 10: Wound Care Management, Germany,
Overall Revenues ($ mn), Forecast, 2007-2012 31
Table 11: Wound Care
Management, Germany, Category Revenues ($ mn), 2000-2012 32
Table 12:
Wound Care Management, Germany, Category Revenues ($ mn), Historic, 2000-2007
33
Table 13: Wound Care Management, Germany, Category Revenues ($ mn),
Forecast, 2007-2012 34
Table 14: Wound Care Management, Germany, Category
Volume (Units), 2000-2012 35
Table 15: Wound Care Management, Germany,
Category Volume (Units), Historic, 2000-2007 36
Table 16: Wound Care
Management, Germany, Category Volume (Units), Forecast, 2007-2012 37
Table
17: Wound Care Management in Germany, Overall, Company Share by Revenue ($
mn), 2005-2006 38
Table 18: Wound Closur e Devices, Germany, Overall
Revenues ($ mn), Historic, 2000-2007 39
Table 19: Wound Closure Devices,
Germany, Overall Revenues ($ mn), Forecast, 2007-2012 40
Table 20: Wound
Closure Devices, Germany, Revenue by Segment ($ mn), Historic, 2000-2007
41
Table 21: Wound Closure Devices, Germany, Revenue by Segment ($ mn),
Forecast, 2007-2012 42
Table 22: Skin Closure Devices, Germany, Overall
Revenues ($ mn), Historic, 2000-2007 43
Table 23: Skin Closure Devices,
Germany, Overall Revenues ($ mn), Forecast, 2007-2012 44
Table 24:
Hemostats, Germany, Overall Revenues ($ mn), Historic, 2000-2007 45
Table
25: Hemostats, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 46
Table 26: Tissue Sealants, Germany, Overall Revenues ($ mn), Historic,
2000-2007 47
Table 27: Tissue Sealants, Germany, Overall Revenues ($ mn),
Forecast, 2007-2012 48
Table 28: Wound Closure Devices, Germany, Overall
Volume (Units), Historic, 2000-2007 49
Table 29: Wound Closure Devices,
Germany, Overall Volume (Units), Forecast, 2007-2012 50
Table 30: Skin
Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007 51
Table 31: Skin Closure Devices, Germany, Overall Volume (Units), Forecast,
2007-2012 52
Table 32: Tissue Sealants, Germany, Overall Volume (Units),
Historic, 2000-2007 53
Table 33: Tissue Sealants, Germany, Overall Volume
(Units), Forecast, 2007-2012 54
Table 34: Hemostats, Germany, Overall
Volume (Units), Historic, 2000-2007 55
Table 35: Hemostats, Germany,
Overall Volume (Units), Forecast, 2007-2012 56
Table 36: Hemostats,
Germany, Average Price ($), Historic, 2000-2007 57
Table 37: Hemostats,
Germany, Average Price ($), Forecast, 2007-2012 58
Table 38: Tissue
Sealants, Germany, Average Price ($), Historic, 2000-2007 59
Table 39:
Tissue Sealants, Germany, Average Price ($), Forecast, 2007-2012 60
Table
40: Skin Closure Devices, Germany, Average Price ($), Historic, 2000-2007
61
Table 41: Skin Closure Devices, Germany, Average Price ($), Forecast,
2007-2012 62
Table 42: Wound Closure Devices, Germany, Distribution Share
by Revenue ($ mn) , 2005-2006 63
Table 43: Wound Closure Devices, Germany,
Company Share by Revenue ($ mn) , 2005-2006 64
Table 44: Ostomy, Germany,
Overall Revenues ($ mn), Historic, 2000-2007 65
Table 45: Ostomy, Germany,
Overall Revenues ($ mn), Forecast, 2007-2012 66
Table 46: Ostomy, Germany,
Overall Volume (Units), Historic, 2000-2007 67
Table 47: Ostomy, Germany,
Overall Volume (Units), Forecast, 2007-2012 68
Table 48: Ostomy, Germany,
Average Price ($), Historic, 2000-2007 69
Table 49: Ostomy, Germany,
Average Price ($), Forecast, 2007-2012 70
Table 50: Ostomy, Germany,
Distribution Share by Revenue ($ mn) , 2005-2006 71
Table 51: Ostomy,
Germany, Company Share by Revenue ($ mn), 2005-2006 72
Table 52: Advanced
Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 73
Table 53: Advanced Wound Management, Germany, Overall Revenues ($ mn),
Forecast, 2007-2012 74
Table 54: Advanced Wound Management, Germany,
Overall Volume (Units), Historic, 2000-2007 75
Table 55: Advanced Wound
Management, Germany, Overall Volume (Units), Forecast, 2007-2012 76
Table
56: Advanced Wound Management, Germany, Average Price ($), Historic, 2000-2007
77
Table 57: Advanced Wound Management, Germany, Average Price ($),
Forecast, 2007-2012 78
Table 58: Advanced Wound Management, Germany,
Distribution Share by Revenue ($ mn) , 2005-2006 79
Table 59: Advanced
Wound Management, Germany, Company Share by Revenue ($ mn) , 2005-2006 80
Table 60: Traditional Wound Management, Germany, Overall Revenues ($ mn),
Historic, 2000-2007 81
Table 61: Traditional Wound Management, Germany,
Overall Revenues ($ mn), Forecast, 2007-2012 82
Table 62: Traditional
Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007 83
Table 63: Traditional Wound Management, Germany, Overall Volume (Units),
Forecast, 2007-2012 84
Table 64: Traditional Wound Management, Germany,
Average Price ($), Historic, 2000-2007 85
Table 65: Traditional Wound
Management, Germany, Average Price ($), Forecast, 2007-2012 86
Table 66:
Traditional Wound Management, Germany, Distribution Share by Revenue ($ mn) ,
2005-2006 87
Table 67: Traditional Wound Management, Germany, Company
Share by Revenue ($ mn) , 2005-2006 88
Table 68: Compression Therapy,
Germany, Overall Revenues ($ mn), Historic, 2000-2007 89
Table 69:
Compression Therapy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
90
Table 70: Compression Therapy, Germany, Overall Volume (Units),
Historic, 2000-2007 91
Table 71: Compression Therapy, Germany, Overall
Volume (Units), Forecast, 2007-2012 92
Table 72: Compression Therapy,
Germany, Average Price ($), Historic, 2000-2007 93
Table 73: Compression
Therapy, Germany, Average Price ($), Forecast, 2007-2012 94
Table 74:
Compression Therapy, Germany, Distribution Share by Revenue ($ mn) , 2005-2006
95
Table 75: Compression Therapy, Germany, Company Share by Revenue ($ mn)
, 2005-2006 96
Table 76: HARTMANN GROUP, SWOT Analysis , 2006 102
Table 77: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006
106
Table 78: HARTMANN GROUP, Financial Ratios, Euro Thousand,
2002-2006 107
Table 79: HARTMANN GROUP, Subsidiaries 108
Table
80: HARTMANN GROUP, Subsidiaries (Contd.) 109
Table 81: Ethicon,
Inc., Other Locations 112
Table 82: Ethicon, Inc., Subsidiaries
113
Table 83: Coloplast A/S, SWOT Analysis , 2007 119
Table 84:
Coloplast A/S, Financial Statements, DKK Million, 2003-2007 122
Table
85: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007 123
Table
86: Coloplast A/S, Share Holding Structure 124
Table 87:
Coloplast A/S, Other Locations 124
Table 88: Coloplast A/S,
Subsidiaries 125
Table 89: Coloplast A/S, Subsidiaries (Contd.)
126
Table 90: Smith & Nephew Plc, SWOT Analysis, 2006 136
Table
91: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006
139
Table 92: Smith & Nephew Plc, Financial Ratios, USD Million,
2002-2006 140
Table 93: Smith & Nephew Plc, Other Locations 141
Table 94: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007 150
Table 95: Covidien Ltd./Tyco Healthcare, Financial Statements, USD
Million, 2003-2007 154
Table 96: Covidien Ltd./Tyco Healthcare,
Financial Ratios, USD Million, 2003-2007 155
Table 97: Covidien
Ltd./Tyco Healthcare, Other Locations 156
Table 98: Covidien
Ltd./Tyco Healthcare, Subsidiaries 157
Table 99: Currency Conversion
from USD to Local Currency at 2007 Constant Rate 182
1.2 List of
Figures
Figure 1: Healthcare Structure in Germany, 2000 - 2006 18
Figure 2: Healthcare Expenditure Sources in Germany, 2003 19
Figure 3:
Healthcare Financing Framework in Germany, 2007 20
Figure 4: Wound Care
Management, Germany, Overall Revenues ($ mn), 2000-2012 29
Figure 5: Wound
Care Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 30
Figure 6: Wound Care Management, Germany, Overall Revenues ($ mn), Forecast,
2007-2012 31
Figure 7: Wound Care Management, Germany, Category Revenues
($ mn), 2000-2012 32
Figure 8: Wound Care Management, Germany, Category
Revenues ($ mn), Historic, 2000-2007 33
Figure 9: Wound Care Management,
Germany, Category Revenues ($ mn), Forecast, 2007-2012 34
Figure 10: Wound
Care Management, Germany, Category Volume (Units), 2000-2012 35
Figure 11:
Wound Care Management, Germany, Category Volume (Units), Historic, 2000-2007
36
Figure 12: Wound Care Management, Germany, Category Volume (Units),
Forecast, 2007-2012 37
Figure 13: Wound Care Management in Germany,
Overall, Company Share (%), 2006 38
Figure 14: Wound Closure Devices,
Germany, Overall Revenues ($ mn), Historic, 2000-2007 39
Figure 15: Wound
Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 40
Figure 16: Wound Closure Devices, Germany, Revenue by Segment ($ mn),
Historic, 2000-2007 41
Figure 17: Wound Closure Devices, Germany, Revenue
by Segment ($ mn), Forecast, 2007-2012 42
Figure 18: Skin Closure Devices,
Germany, Overall Revenues ($ mn), Historic, 2000-2007 43
Figure 19: Skin
Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 44
Figure 20: Hemostats, Germany, Overall Revenues ($ mn), Historic, 2000-2007
45
Figure 21: Hemostats, Germany, Overall Revenues ($ mn), Forecast,
2007-2012 46
Figure 22: Tissue Sealants, Germany, Overall Revenues ($ mn),
Historic, 2000-2007 47
Figure 23: Tissue Sealants, Germany, Overall
Revenues ($ mn), Forecast, 2007-2012 48
Figure 24: Wound Closure Devices,
Germany, Overall Volume (Units), Historic, 2000-2007 49
Figure 25: Wound
Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012 50
Figure 26: Skin Closure Devices, Germany, Overall Volume (Units), Historic,
2000-2007 51
Figure 27: Skin Closure Devices, Germany, Overall Volume
(Units), Forecast, 2007-2012 52
Figure 28: Tissue Sealants, Germany,
Overall Volume (Units), Historic, 2000-2007 53
Figure 29: Tissue Sealants,
Germany, Overall Volume (Units), Forecast, 2007-2012 54
Figure 30:
Hemostats, Germany, Overall Volume (Units), Historic, 2000-2007 55
Figure
31: Hemostats, Germany, Overall Volume (Units), Forecast, 2007-2012 56
Figure 32: Hemostats, Germany, Average Price ($), Historic, 2000-2007 57
Figure 33: Hemostats, Germany, Average Price ($), Forecast, 2007-2012 58
Figure 34: Tissue Sealants, Germany, Average Price ($), Historic, 2000-2007
59
Figure 35: Tissue Sealants, Germany, Average Price ($), Forecast,
2007-2012 60
Figure 36: Skin Closure Devices, Germany, Average Price ($),
Historic, 2000-2007 61
Figure 37: Skin Closure Devices, Germany, Average
Price ($), Forecast, 2007-2012 62
Figure 38: Wound Closure Devices,
Germany, Distribution Share (%), 2006 63
Figure 39: Wound Closure Devices,
Germany, Company Share (%), 2006 64
Figure 40: Ostomy, Germany, Overall
Revenues ($ mn), Historic, 2000-2007 65
Figure 41: Ostomy, Germany,
Overall Revenues ($ mn), Forecast, 2007-2012 66
Figure 42: Ostomy,
Germany, Overall Volume (Units), Historic, 2000-2007 67
Figure 43: Ostomy,
Germany, Overall Volume (Units), Forecast, 2007-2012 68
Figure 44: Ostomy,
Germany, Average Price ($), Historic, 2000-2007 69
Figure 45: Ostomy,
Germany, Average Price ($), Forecast, 2007-2012 70
Figure 46: Ostomy,
Germany, Company Share (%), 2006 72
Figure 47: Advanced Wound Management,
Germany, Overall Revenues ($ mn), Historic, 2000-2007 73
Figure 48:
Advanced Wound Management, Germany, Overall Revenues ($ mn), Forecast,
2007-2012 74
Figure 49: Advanced Wound Management, Germany, Overall Volume
(Units), Historic, 2000-2007 75
Figure 50: Advanced Wound Management,
Germany, Overall Volume (Units), Forecast, 2007-2012 76
Figure 51:
Advanced Wound Management, Germany, Average Price ($), Historic, 2000-2007
77
Figure 52: Advanced Wound Management, Germany, Average Price ($),
Forecast, 2007-2012 78
Figure 53: Advanced Wound Management, Germany,
Distribution Share (%), 2006 79
Figure 54: Advanced Wound Management,
Germany, Company Share (%), 2006 80
Figure 55: Traditional Wound
Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 81
Figure 56: Traditional Wound Management, Germany, Overall Revenues ($ mn),
Forecast, 2007-2012 82
Figure 57: Traditional Wound Management, Germany,
Overall Volume (Units), Historic, 2000-2007 83
Figure 58: Traditional
Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012 84
Figure 59: Traditional Wound Management, Germany, Average Price ($), Historic,
2000-2007 85
Figure 60: Traditional Wound Management, Germany, Average
Price ($), Forecast, 2007-2012 86
Figure 61: Traditional Wound Management,
Germany, Distribution Share (%), 2006 87
Figure 62: Traditional Wound
Management, Germany, Company Share (%), 2006 88
Figure 63: Compression
Therapy, Germany, Overall Revenues ($ mn), Historic, 2000-2007 89
Figure
64: Compression Therapy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012
90
Figure 65: Compression Therapy, Germany, Overall Volume (Units),
Historic, 2000-2007 91
Figure 66: Compression Therapy, Germany, Overall
Volume (Units), Forecast, 2007-2012 92
Figure 67: Compression Therapy,
Germany, Average Price ($), Historic, 2000-2007 93
Figure 68: Compression
Therapy, Germany, Average Price ($), Forecast, 2007-2012 94
Figure 69:
Compression Therapy, Germany, Distribution Share (%), 2006 95
Figure 70:
Compression Therapy, Germany, Company Share (%), 2006 96
Figure 71:
HARTMANN GROUP, Value Chain Analysis 101
Figure 72: Coloplast A/S,
Value Chain Analysis 117
Figure 73: Smith & Nephew Plc, Value Chain
Analysis 134
Figure 74: Covidien Ltd./Tyco Healthcare, Value Chain
Analysis 148
Figure 75: Flowchart for Classification of Non-invasive
Devices in Germany, 2007 162
Figure 76: Flowchart for Classification of
Invasive Devices in Germany, 2007 163
Figure 77: Flowchart for
Classification of Invasive Devices in Germany, 2007 164
Figure 78:
Classification of Invasive Devices in Germany, 2007 165
Figure 79:
Classification of Invasive Devices in Germany, 2007 166
Figure 80:
Flowchart for Classification of Active Devices in Germany, 2007 167
Figure
81: Flowchart for Classification of Active Devices in Germany, 2007 168
Figure 82: Flowchart for Classification of Devices except Non-invasive,
Invasive and Active Devices in Germany, 2007 169
Figure 83: Conformity
Assessment of Class-I Medical Devices in Germany, 2007 170
Figure 84:
Conformity Assessment of Class-IIa Medical Devices in Germany, 2007 171
Figure 85: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007
172
Figure 86: Conformity Assessment of Class-III Medical Devices in
Germany, 2007 173
Figure 87: Global Markets Direct Methodology 178
